Northern Trust
NMTC icon

Northern Trust’s NeuroOne Medical Technologies NMTC Stock Holding History

Northern Trust’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Buy
21,398
+2,711
+15% +$11.1K ﹤0.01% 4220
2026
Q1 		$87.1K Hold
18,687
– – ﹤0.01% 4136
2025
Q4 		$85K Hold
18,687
– – ﹤0.01% 4166
2025
Q3 		$99.6K Buy
18,687
+10,525
+129% +$51.5K ﹤0.01% 4139
2025
Q2 		$33.2K Hold
8,162
– – ﹤0.01% 4296
2025
Q1 		$41.6K Buy
8,162
+3,115
+62% +$19.8K ﹤0.01% 4252
2024
Q4 		$25K Hold
5,047
– – ﹤0.01% 4357
2024
Q3 		$30K Hold
5,047
– – ﹤0.01% 4285
2024
Q2 		$24.2K Hold
5,047
– – ﹤0.01% 4314
2024
Q1 		$36.3K Hold
5,047
– – ﹤0.01% 4270
2023
Q4 		$47.8K Buy
5,047
+1,725
+52% +$12.7K ﹤0.01% 4245
2023
Q3 		$17.7K Hold
3,322
– – ﹤0.01% 4350
2023
Q2 		$23.9K Hold
3,322
– – ﹤0.01% 4372
2023
Q1 		$32.1K Hold
3,322
– – ﹤0.01% 4365
2022
Q4 		$23.9K Buy
3,322
+759
+30% +$6.79K ﹤0.01% 4454
2022
Q3 		$26K Hold
2,563
– – ﹤0.01% 4499
2022
Q2 		$13K Hold
2,563
– – ﹤0.01% 4673
2022
Q1 		$17K Hold
2,563
– – ﹤0.01% 4680
2021
Q4 		$30K Buy
+2,563
New +$41.5K ﹤0.01% 4668

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust's NMTC Position: Q2 2026 in Review

Northern Trust increased its NeuroOne Medical Technologies (NMTC) stake by 15% in Q2 2026, buying an estimated $11.1K and bringing the position to 21,398 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #4220.

Northern Trust first reported a position in NMTC in Q4 2021 and has held it in 19 quarters since. The position peaked at $99.6K in Q3 2025. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Northern Trust held 21,398 shares of NeuroOne Medical Technologies worth $65K as of Q2 2026.
  • Northern Trust bought 2,711 NeuroOne Medical Technologies shares in Q2 2026, an estimated $11.1K.
  • NeuroOne Medical Technologies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4220 holding.
  • Northern Trust first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's NeuroOne Medical Technologies position peaked at $99.6K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.